Business Opportunities

Opto Circuits get CE certificate for portable pulse oximeter

BS Reporter / Bangalore August 11, 2009, 10:27 IST Opto Circuits (India) Limited (OCI), the Bangalore-based maker of medical devices has announced it has received CE mark certification for its latest product, a pocket sized finger pulse oximeter (SpO2 monitor), named M50 NanoSAT. It is one of the lightest such products available in the market today, the company said. Jan cement sales in high double-digit The CE mark certifies that it has met EU consumer safety, health and environmental requirements. Vinod Ramnani, chairman and managing director, Opto Circuits said, "Due to the device"s ready availability, it will be useful for sudden monitoring needs such as the global H1N1 (swine ful) pandemic that is in progress worldwide." Pulse oximetry (detection of arterial oxygen saturation and heart beat rate) is one of the five vital signs that a patient is monitored for in medical care environments. The NanoSAT, weighing only 45 gms, detects and assesses blood oxygen saturation and pulse rate with the help of an integrated optical soft sensor, enhancing patient comfort and accuracy of measurements. The product can also be used for home healthcare and physician office applications, the company said in a release. It will also be useful for SpO2 spot checks in hospitals and EMS centres. The device has LCD backlit display and can run up to 100 hours in continuous operation with one CR2 Lithium Manganese battery.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Govt may import rice to meet shortfall
India may import rice if domestic supplies are inadequate to meet the government’s requirements for the so-called central pool, a minister said.
Popular Articles
payday loans no faxing

Pyramid Saimira suffers Rs 100-cr loss
Chennai-based Pyramid Saimira Theatre Ltd (PSTL) said the company suffered a business loss of over Rs 100 crore last year which resulted in an erosion of working capital. Meanwhile, N Narayanan, one of the promoters of the company, took over as the new chairman from P S Saminathan, who will continue to remain managing director.

Novartis gains on getting patent right
Novartis finally ended with a Rs 21 or 3.6% gain at Rs 590. Around 30,063 shares changed hands at the counter today.